Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)

NCT02882828 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT02882828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02882828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)
Lead sponsor
University Hospital, Limoges
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2016
Completion date
March 31, 2020
Enrollment
134 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

allograft